Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
OTR3 Logo
OTR3 Growth Score
58
CB Rank
145318
Heat Score
60
OTR3 is a biotechnology firm that provides solutions for tissue regeneration through the use of matrix therapy.
Founded
obfuscation
PrivateGrant Paris, Ile-de-France, France11-50 www.otr3.com/
Biotechnology
Cosmetics
Medical Device
Veterinary
Overview

OTR3
Total Funding
obfuscation
Growth Score
58
Heat Score
60

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score58
-6 pts
in past quarter
Heat Score 60
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About OTR3

CB Rank
145318
OTR3 is a biotechnology firm that provides solutions for tissue regeneration through the use of matrix therapy.
Founded
obfuscation
PrivateGrant Paris, Ile-de-France, France11-50 www.otr3.com/
Biotechnology
Cosmetics
Medical Device
Veterinary

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name OTR3 SAS
Also Known As Organes Tissus Regeneration Reparation Remplacement
Operating Status Active
Company Type For Profit
Founders  Denis Barritault, Jean-Pierre Caruelle
About the Company

OTR3 is a biotechnology company founded by Professors Denis Barritault and Jean-Pierre Caruelle† from the University of Paris-East Créteil in 2000, laureates of the French national competition for the creation of the best innovative company. Known for their pioneering work on growth factors – the discovery of FGF, HARP/PTN – they invented the

RGTA® Technology (ReGeneraTing Agents), a new therapeutic class in regenerative medicine.

Phone Number +33 (0)1 83 64 23 00
Contact Email contact@otr3.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CACIPLIQ20®
A class III medical device using RGTA® technology for wound healing, designed to accelerate healing of chronic and hard-to-heal wounds.
OTR4132
A neuroprotective agent in clinical trials aimed at improving functional recovery after acute ischemic stroke following thrombectomy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant
obfuscation
Grant - OTR3 Logo
Grant - OTR3
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EISMEA Logo
EISMEA
—
Grant - OTR3 Logo
Grant - OTR3
—
EISMEA Logo
EISMEA
—
Grant - OTR3 Logo
Grant - OTR3
—
EISMEA Logo
EISMEA
—
Grant - OTR3 Logo
Grant - OTR3
—
EISMEA Logo
EISMEA
—
Grant - OTR3 Logo
Grant - OTR3
—
EISMEA Logo
EISMEA
—
Grant - OTR3 Logo
Grant - OTR3
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Contacts 5

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

72
-76.62%
 in past month

IT Spend

$262.4KThis year, OTR3 is projected to spend $262.4K on IT, according to Aberdeen.

Actively Used Products

15OTR3 uses 15 technology products and services including HTML5, Bootstrap, and  Wistia, according to G2 Stack.

Active Website Tech Count

4OTR3 is actively using 4 technologies for its website, according to BuiltWith. These include Viewport Meta, IPv6, and  CommonCrawl Top 5m.

Total IP

2The intellectual property of OTR3 includes 2 registered patents primarily in the 'Testing' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is OTR3's headquarters? OTR3 is located in Paris, Ile-de-France, France.Who invested in OTR3? OTR3 is funded by EISMEA.When was the last funding round for OTR3? OTR3 closed its last funding round on
obfuscation
from a Grant round.Who are OTR3's competitors? Alternatives and possible competitors to OTR3 may include Molnlycke Health Care, Solventum, and  Integra LifeSciences.How much funding has OTR3 raised to date? OTR3 has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|